These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15681552)

  • 1. Insights into the role of progesterone receptors in breast cancer.
    Fuqua SA; Cui Y; Lee AV; Osborne CK; Horwitz KB
    J Clin Oncol; 2005 Feb; 23(4):931-2; author reply 932-3. PubMed ID: 15681552
    [No Abstract]   [Full Text] [Related]  

  • 2. Time for reappraisal of progesterone-receptor testing in breast cancer management.
    MacGrogan G; de Mascarel I; Sierankowski G; Mauriac L; Debled M; Durand M; De Lara CT; Avril A; Picot V; Mathoulin-Pélissier S
    J Clin Oncol; 2005 Apr; 23(12):2870-1; author reply 2871. PubMed ID: 15838009
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estradiol and progesterone receptors in breast cancer].
    Medina M; Calzada L; Loustaunau E; Torres R; Zárate A
    Arch Invest Med (Mex); 1987; 18(3):235-40. PubMed ID: 3426358
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations for the immunohistochemistry of the hormonal receptors on paraffin sections in breast cancer. Update 1999. Group for Evaluation of Prognostic Factors using Immunohistochemistry in Breast Cancer (GEFPICS-FNCLCC)].
    Ann Pathol; 1999 Sep; 19(4):336-43. PubMed ID: 10544774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative evaluation of proliferative activity of breast tumors of different estrogen-progesterone receptor status].
    Ellinidi VN; Anikeeva NV; Goncharova OA; Krasnozhon DA
    Vopr Onkol; 2005; 51(2):197-9. PubMed ID: 16223000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone receptors in human breast cancer.
    Seckinger D
    J Fla Med Assoc; 1980 Feb; 67(2):198-202. PubMed ID: 7359111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology].
    Balaton AL; Coindre JM; Collin F; Ettore F; Fiche M; Jacquemier J; Le Doussal V; Mandard AM; Mathieu MC; Migeon C; Simony-Lafontaine J; Treilleux I; Verriele V; Vilain MO; Zafrani B
    Ann Pathol; 1996; 16(2):144-8. PubMed ID: 8767687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor testing: not the right time to be buried.
    Colozza M; Larsimont D; Piccart MJ
    J Clin Oncol; 2005 Jun; 23(16):3867-8; author reply 3869-70. PubMed ID: 15923594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination and significance of hormone receptors in breast carcinoma].
    Marugo M; Bernasconi D; Sorice G; Fazzuoli L
    Ann Ital Chir; 1991; 62(5):461-5. PubMed ID: 1801624
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary: hormone receptor testing in breast cancer: a distress signal from Canada.
    Allred DC
    Oncologist; 2008 Nov; 13(11):1134-6. PubMed ID: 18987048
    [No Abstract]   [Full Text] [Related]  

  • 11. [Estrogen and progesterone receptors in breast cancer].
    Cohen Y; Borovik R
    Harefuah; 1985 Dec; 109(11):350-2. PubMed ID: 3912300
    [No Abstract]   [Full Text] [Related]  

  • 12. Time to stop progesterone receptor testing in breast cancer management.
    Olivotto IA; Truong PT; Speers CH; Bernstein V; Allan SJ; Kelly SJ; Lesperance ML
    J Clin Oncol; 2004 May; 22(9):1769-70. PubMed ID: 15118010
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone receptors in defining breast cancer prognosis--time for a rethink?
    Speirs V; Shaaban AM
    Nat Clin Pract Oncol; 2007 Apr; 4(4):204-5. PubMed ID: 17392711
    [No Abstract]   [Full Text] [Related]  

  • 14. ERCC1 expression in triple negative breast carcinoma: the paradox revisited.
    Sidoni A; Cartaginese F; Colozza M; Gori S; Crinó L
    Breast Cancer Res Treat; 2008 Oct; 111(3):569-70. PubMed ID: 17987380
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunohistochemical analysis of hormonal receptors in cancer of the breast. Current evaluation].
    Jacquemier J; Hassoun J; Martin PM
    Ann Pathol; 1989; 9(3):165-9. PubMed ID: 2667531
    [No Abstract]   [Full Text] [Related]  

  • 16. Assay of estrogen and progesterone receptors in small samples of breast cancer: I. Mathematical analysis of total binding data.
    Piantanelli L; Rossolini G; Viticchi C; Basso A
    Boll Soc Ital Biol Sper; 1994; 70(8-9):221-7. PubMed ID: 7893480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer is heterogeneous.
    Guinebretiere JM
    J Clin Oncol; 2009 Jun; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen and progesterone receptors in breast cancer: a new approach to measure.
    Lee SH
    Conn Med; 1980 Oct; 44(10):622-5. PubMed ID: 7226762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prediction of therapeutic response in breast carcinoma: predictive factors].
    Nesković-Konstantinović Z
    Srp Arh Celok Lek; 1999; 127(3-4):131-6. PubMed ID: 10500437
    [No Abstract]   [Full Text] [Related]  

  • 20. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?
    Arnould L; Coudert B; Fumoleau P
    J Clin Oncol; 2009 Jun; 27(16):2733; author reply 2734-5. PubMed ID: 19380432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.